Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.
2.

Movement disorders associated with neuroleptic treatment.

Wirshing WC.

J Clin Psychiatry. 2001;62 Suppl 21:15-8. Review.

3.

The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.

Barnes TR.

Psychiatr Dev. 1987 Winter;5(4):301-19. Review.

PMID:
2895467
4.

Changing epidemiology of tardive dyskinesia: an overview.

Jeste DV, Wyatt RJ.

Am J Psychiatry. 1981 Mar;138(3):297-309. Review.

PMID:
6110344
5.

Movement disorders with neuroleptic drug treatment.

Tarsy D.

Psychiatr Clin North Am. 1984 Sep;7(3):453-71. Review.

PMID:
6148742
6.

The evaluation and treatment of neuroleptic-induced movement disorders.

Gardos G, Cole JO.

Harv Rev Psychiatry. 1995 Sep-Oct;3(3):130-9. Review.

PMID:
9384940
7.

Prevalence of tardive dyskinesia.

Tepper SJ, Haas JF.

J Clin Psychiatry. 1979 Dec;40(12):508-16. Review.

PMID:
40964
8.

Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

Kane JM, Smith JM.

Arch Gen Psychiatry. 1982 Apr;39(4):473-81. Review.

PMID:
6121548
9.

Tardive dyskinesia.

Casey DE.

West J Med. 1990 Nov;153(5):535-41. Review.

10.
11.

[Neuroleptic-induced movement disorders: historical perspectives].

Wolf MA, Yassa R, Llorca PM.

Encephale. 1993 Nov-Dec;19(6):657-61. Review. French.

PMID:
12404786
12.
13.

Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.

Barnes TR, McPhillips MA.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S49-57. Review.

PMID:
9690971
14.

Adverse effects of antipsychotic drugs.

Malhotra AK, Litman RE, Pickar D.

Drug Saf. 1993 Dec;9(6):429-36. Review.

PMID:
7907481
15.

Drug-induced movement disorders.

Jiménez-Jiménez FJ, García-Ruiz PJ, Molina JA.

Drug Saf. 1997 Mar;16(3):180-204. Review.

PMID:
9098656
16.

Management of tardive dyskinesia: current update.

Simpson GM, Pi EH, Sramek JJ Jr.

Drugs. 1982 May;23(5):381-93. Review.

PMID:
7047137
17.

Review article: metoclopramide and tardive dyskinesia.

Rao AS, Camilleri M.

Aliment Pharmacol Ther. 2010 Jan;31(1):11-9. doi: 10.1111/j.1365-2036.2009.04189.x. Review.

18.

Selective serotonin-reuptake inhibitor-induced movement disorders.

Gerber PE, Lynd LD.

Ann Pharmacother. 1998 Jun;32(6):692-8. Review.

PMID:
9640489
19.

Drug-induced movement disorders in children.

Rodnitzky RL.

Semin Pediatr Neurol. 2003 Mar;10(1):80-7. Review.

PMID:
12785751
20.

Neuroleptics in pediatric psychiatry.

Whitaker A, Rao U.

Psychiatr Clin North Am. 1992 Mar;15(1):243-76. Review.

PMID:
1347940

Supplemental Content

Support Center